+ All Categories
Home > Documents > Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... ·...

Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... ·...

Date post: 12-Aug-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
63
Design Strategies and Measurement of association Dr Olarewaju Sunday
Transcript
Page 1: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Design Strategies and Measurement of association

Dr Olarewaju Sunday

Page 2: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

What are the objectives of epidemiology?

1. Quantify burden (Time, Place & Person)-Measurement tools

2. Identify the determinant factors3. Establish causal relationship between

exposure and outcome- Study designs

Page 3: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 4: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Experimental studies

Page 5: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 6: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Experiment may be carried out in one of the following settings

1) Clinical setting- carried out on patients, for testing a newtreatment, mostly ‘Randomized CLINICAL trial’.

2) Field Trial – carried out in the community- on healthyindividuals- mostly for testing prophylactic agents like a vaccine-This can employ a randomized controlled design or a nonrandomized design

3) Community Trial –carried out in a community-the interventionhas to be made at public level

Page 7: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Basic Steps in Randomized Controlled Trial

• The basic steps in conducting a RCT include the following:

• 1. Drawing up a protocol • 2. Selecting reference and experimental

populations • 3. Randomization • 4. Manipulation or intervention • 5. Follow-up • 6. Assessment of outcome

Page 8: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Continue in next session.

Blinding/Confounders

Page 9: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Observational studies

Page 10: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 11: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 12: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 13: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 14: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 15: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Cross sectional descriptive studies

Page 16: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Cross sectional studies

Design of a cross-sectional study

• We define a populationand determine thepresence or absence ofexposure and thepresence or absence ofdisease for eachindividual

• Each subject then canbe categorized into oneof four possiblesubgroups

Page 17: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Cross sectional studies

FIGURE 2-Design of a cross-sectional study: II FIGURE 3-Design of a cross-sectional study: III.

The findings can be viewed in a 2 × 2 table, as seen in Figures which also show the two approaches to interpreting the findings from such studies.

Page 18: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 19: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 20: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Cohort study

Analytical study

Page 21: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 22: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 23: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 24: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 25: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 26: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 27: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 28: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 29: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Advantages

Page 30: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Disadvantages

Page 31: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 32: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 33: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Exercise

Exposure Lung Cancer No lung Cancer

smokers 70 6930 7000

Non Smokers 3 2997 3000

Total 73 9927 10,000

Page 34: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Case control studies

Page 35: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 36: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 37: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 38: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 39: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 40: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 41: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 42: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 43: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 44: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Association and Causation

Guidelines of Causality

Page 45: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

APPROACHES TO ETIOLOGY IN HUMAN POPULATIONS

A frequent sequence of studies in human populations

Strength of evidence based on type of epidemiological design

Page 46: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Two step process to carry out studies and evaluate evidence

1.Determine if an association is present- Ecologic studies: studies of group

characteristics- Cross-sectional studies: studies at one

particular time- Case-control or cohort studies: studies of

individual characteristics.2. If an association is demonstrated,

determine whether the observed association is likely to be a causal one using pre-determined criteria.

Page 47: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Nine guidelines for judging whether an association is causal

Temporal relationship

Strength of association

Dose responserelationship

Replication of the findings

Biologic plausibility

Consideration of alternate explanations

Cessation of exposure

Specificity of the association

Consistency with other knowledge

Page 48: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Temporal Relationship

• Exposure to the factor must have occurred before the disease developed.

• Easiest to establish in a cohort study• Length of interval between exposure and disease

very important – If the disease develops in a period of time too soon

after exposure, the causal relationship is called into question

Page 49: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Strength of Association

• The larger the RELATIVE RISK OR ODDS RATIO, the higher the likelihood that the relationship is causal

• However, care must be taken to examine confidence intervals and sample size– For example, if the confidence interval is wide (e.g., 1.8

- 22.6), an OR of 12.0 is less strong because we are less confident of the strength of the odds ratio

Page 50: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Strength of association

Which odds ratio would you be more likely to infer causation from?

OR#1: OR = 1.4 95% CI = (1.2 - 1.7)

OR#2: OR = 9.8 95% CI = (1.8 - 12.3)

OR#3: OR = 6.6 95% CI = (5.9 - 8.1)

Page 51: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Dose-Response Relationship

• With increasing dose, there is increasing risk of disease

• This is not considered necessary for a causal relationship, but does provide additional evidence that a causal relationship exists

Page 52: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Replication of the Findings

• If there is a true causal relationship between exposure and disease, the expectation is that we would see the association consistently in other (NOT necessarily all) subgroups of the population

Page 53: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Biologic plausibility

• Consistency ofepidemiologic plausibilitywith existing biologicknowledge

• Requires knowledge ofthe biologic etiology ofdisease

• Gregg’s observations onrubella and congenitalcataracts preceded anyknowledge of teratogenicviruses

Congenital Cataract

Rubella Virus

Page 54: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Consideration of alternate explanations

Requires a knowledge of the literature and known risk factors for the disease

Page 55: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Cessation of exposure

• Upon elimination or reduction of exposure to the factor, the risk of disease declines.

• HOWEVER, in certain cases, the damage may be irreversible.

• Example: Emphysema is not reversed with the cessation of smoking, but its progression is reduced.

Page 56: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Specificity of the Association

• The weakest of the criteria (should probably be eliminated)

• Specific exposure is associated with only one disease

• This is used by tobacco companies to argue that smoking is not causal in lung cancer– Smoking is associated with many diseases

• If anything, may provide support for a causal relationship, but does not negate if not present

Page 57: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Diseases screening

Page 58: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 59: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 60: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 61: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 62: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly
Page 63: Design Strategies and Measurement of associationoer.unimed.edu.ng/LECTURE NOTES/1/1/Olarewaju... · 1) Clinical setting- carried out on patients, for testing a new treatment, mostly

Exercise


Recommended